Arcus Biosciences, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC RCUS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

144,093

Value ($000)

3,434

Weight

0.0%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	3,434	0.0%	144,093	12/31/2025
2025 Q3	11/14/2025	1,194	0.0%	87,771	9/30/2025
2025 Q2	8/14/2025	1,413	0.0%	173,598	6/30/2025
2025 Q1	5/19/2025	765	0.0%	97,423	3/31/2025
2024 Q4	2/14/2025	923	0.0%	62,014	12/31/2024
2024 Q3	11/14/2024	1,069	0.0%	69,886	9/30/2024
2024 Q2	8/14/2024	1,475	0.0%	96,852	6/30/2024
2024 Q1	5/15/2024	7,138	0.0%	378,063	3/31/2024
2023 Q4	2/14/2024	7,615	0.0%	398,666	12/31/2023
2023 Q3	11/13/2023	7,289	0.0%	406,047	9/30/2023
2023 Q2	8/11/2023	7,502	0.0%	411,300	6/30/2023
2023 Q1	5/15/2023	7,502	0.0%	411,300	3/31/2023
2022 Q4	2/14/2023	8,309	0.0%	401,769	12/31/2022
2022 Q3	11/14/2022	11,687	0.0%	446,734	9/30/2022
2022 Q2	8/12/2022	11,417	0.0%	450,555	6/30/2022
2022 Q1	5/16/2022	9,905	0.0%	313,838	3/31/2022
2021 Q4	2/14/2022	9,762	0.0%	241,211	12/31/2021
2021 Q3	11/15/2021	1,450	0.0%	41,577	9/30/2021
2021 Q2	8/16/2021	1,017	0.0%	37,020	6/30/2021
2021 Q1	5/14/2021	937	0.0%	33,386	3/31/2021
2020 Q4	3/1/2021	979	0.0%	37,715	12/31/2020
2020 Q3	11/13/2020	391	0.0%	22,800	9/30/2020
2020 Q2	8/14/2020	762	0.0%	30,815	6/30/2020